3-Furan-2-yl-3-oxo-propionic acid ethyl ester, 95.0%, 5g

N-[(5-Chloro-3-oxido-1H-benzotriazol-1-yl)-4-morpholinylmethylene]-N-methylmethanaminium hexafluorophosphate, 98%, 5g

Tert-butyl 4-(4-methoxyphenyl)piperazine-1-carboxylate, 95%, 1g

Developing chambers for TLC, Suitable for, up to 5 plates up to 20 x 20 cm plate size, 1 Piece(s)

Methyl 2-cyclopentanonecarboxylate, 95.0%, 100g

2,4,6-Tribromobenzenesulfonyl chloride, 97.0%, 1g

5-Bromo-2-chloro-6-methylnicotinonitrile, 95.0%, 1g

1-Benzyl-4-methylpiperidin-3-ol, 95.0%, 1g

5,7-Dichloro-2-isopropyl-2H-pyrazolo[4,3-d]pyrimidine, 95.0%, 10g

6-Fluoro-2,3,4,9-tetrahydro-1H-carbazole, 95.0%, 100mg

(1H-Imidazole-4,5-diyl)dimethanol, 95.0%, 1g

(4-tert-butyl-1,3-thiazol-2-yl)methanol, 95.0%, 5g

1-(3-Chlorophenyl)ethylamine, 95.0%, 5g